Chios Mastic in Well-Controlled Hypertension: Findings From the HYPER-MASTIC Randomized Controlled Trial.
A natural mastic supplement shows measurable vascular benefits in people with harder-to-control high blood pressure, warranting study in higher-risk groups.
This randomized controlled trial examined Chios Mastic in Well-Controlled Hypertension: Findings From the HYPER-MASTIC Randomized Controlled Trial. The PubMed abstract reports that Transcriptomic findings suggest biologically meaningful vascular effects in individuals with higher residual cardiovascular risk, supporting future investigation in higher-risk populations.
What the study was
- Study design
- Randomized controlled trial
- Population
- patients with adequately controlled hypertension, driven partly by inflammation, oxidative stress and endoth
- Sample size
- 106
- Category
- Prevention
- Maturity
- Validated
- Journal
- Pharmacology research & perspectives
Why it surfaced
Score 7/10 reflects randomized controlled trial evidence with abstract only access; genuine match to Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.